Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.38 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 10/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 9/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27214521 | 1.00 | NPC1 (0.38) | NPC1RAB9ALMNASMN1; SMN2PTGS1 | |
| SCHEMBL27214519 | 1.00 | NPC1 (0.38) | NPC1RAB9ALMNASMN1; SMN2PTGS1 | |
| SCHEMBL27231041 | 1.00 | NPC1 (0.38) | NPC1RAB9ALMNASMN1; SMN2PTGS1 | |
| SCHEMBL27231331 | 1.00 | NPC1 (0.38) | NPC1RAB9ALMNASMN1; SMN2PTGS1 | |
| SCHEMBL119790 | 1.00 | NPC1 (0.38) | NPC1RAB9ALMNASMN1; SMN2PTGS1 | |
| SCHEMBL27214520 | 1.00 | NPC1 (0.38) | NPC1RAB9ALMNASMN1; SMN2PTGS1 | |
| SCHEMBL1427225 | 1.00 | NPC1 (0.38) | NPC1RAB9ALMNASMN1; SMN2PTGS1 | |
| SCHEMBL16269456 | 0.84 | NPC1 (0.36) | NPC1RAB9ALMNASMN1; SMN2PTGS1 | |
| SCHEMBL17976872 | 0.84 | PTPN1 (0.32) | PTPN1 | |
| SCHEMBL14861496 | 0.83 | PTGS1 (0.35) | NPC1RAB9ALMNASMN1; SMN2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024083676-A1 | LIPID-BASED MICROCAPSULES | FIRMENICH SA (CH) | 2024-04-25 | — | — | WO | disclosed |
| US-20240076583-A1 | HYBRID MICROCAPSULES COMPRISING A REGENERATED BIOPOLYMER | FIRMENICH SA (CH) | 2024-03-07 | — | — | US | disclosed |
| WO-2023217589-A1 | POLYAMIDE MICROCAPSULES | FIRMENICH SA (CH) | 2023-11-16 | — | — | WO | disclosed |
| WO-2023217590-A1 | POLYAMIDE MICROCAPSULES | FIRMENICH SA (CH) | 2023-11-16 | — | — | WO | disclosed |
| EP-3898912-A1 | A METHOD OF COUNTERING MALODOUR IN A WASHING MACHINE COMPRISING THE ADDITION OF A FRAGRANCE PRECURSOR | Givaudan SA (CH) | 2021-10-27 | — | — | EP | disclosed |
| WO-2020125922-A1 | A METHOD OF COUNTERING MALODOUR IN A WASHING MACHINE COMPRISING THE ADDITION OF A FRAGRANCE PRECURSOR | GIVAUDAN SA (CH) | 2020-06-25 | — | — | WO | disclosed |
| EP-3003031-A1 | COATED PARTICLES AND COMPOSITIONS COMPRISING SAME | Vyome Biosciences Pvt Ltd (IN) | 2016-04-13 | — | — | EP | disclosed |
| WO-2014195872-A1 | COATED PARTICLES AND COMPOSITIONS COMPRISING SAME | VYOME BIOSCIENCES PVT. LTD. (IN) | 2014-12-11 | — | — | WO | disclosed |
| EP-2622051-A1 | 4,4-DIMETHYL-DECAL-1-ONE OR -1-OL DERIVATIVES AS PERFUMING INGREDIENTS | Firmenich SA (CH) | 2013-08-07 | — | — | EP | disclosed |
| WO-2012041820-A1 | 4,4-DIMETHYL-DECAL-1-ONE OR -1-OL DERIVATIVES AS PERFUMING INGREDIENTS | FIRMENICH SA (CH) | 2012-04-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240076583-A1 | HYBRID MICROCAPSULES COMPRISING A REGENERATED BIOPOLYMER | CRYZ, MLEC, MITF | NPC1 3878/4885RAB9A 3515/4885LMNA 2568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.